Is Keflex (cephalexin) effective for treating bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin (Keflex) Is Not Recommended as First-Line Treatment for Bacterial Sinusitis

Cephalexin (Keflex) is not recommended as a first-line treatment for bacterial sinusitis due to its inadequate coverage against common respiratory pathogens, particularly Haemophilus influenzae. 1

Appropriate Antibiotic Selection for Bacterial Sinusitis

First-Line Options:

  • Amoxicillin or amoxicillin-clavulanate are the recommended first-line antibiotics for bacterial sinusitis 1, 2
    • Standard dose: Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 2
    • High-dose option: 2000 mg (amoxicillin component) with 125 mg clavulanate twice daily for 5-7 days 2

Second-Line Options (for penicillin allergy):

  • Cefdinir: 300-600 mg twice daily for 5-7 days 2
  • Cefpodoxime: 200-400 mg twice daily for 5-7 days 2
  • Cefuroxime: 250-500 mg twice daily for 5-7 days 2
  • Clarithromycin (in regions with low macrolide resistance) 1

Why Cephalexin Is Not Appropriate for Sinusitis

Cephalexin, as a first-generation cephalosporin, has significant limitations for treating sinusitis:

  1. Poor coverage against H. influenzae - a common pathogen in bacterial sinusitis 1
  2. Inadequate activity against M. catarrhalis - another common sinusitis pathogen 1
  3. Limited efficacy against penicillin-resistant S. pneumoniae strains 1, 2

While an older study from 1985 suggested efficacy of cephalexin in sinusitis 3, more recent guidelines and evidence have established that first-generation cephalosporins like cephalexin are inappropriate for this indication due to their antimicrobial spectrum limitations.

Better Cephalosporin Options for Sinusitis

If a cephalosporin is needed (e.g., in penicillin-allergic patients), second or third-generation options are preferred:

  • Second-generation: Cefuroxime axetil 1, 2
  • Third-generation: Cefpodoxime, cefdinir 1, 2

These agents have demonstrated effectiveness against sinusitis pathogens in clinical trials 4, 5, 6. For example, cefdinir showed similar efficacy to amoxicillin-clavulanate with approximately 90% cure rates 5.

Diagnostic Considerations Before Antibiotic Initiation

Before prescribing any antibiotic, confirm bacterial sinusitis is likely present:

  • Persistent symptoms (nasal discharge/cough) for >10 days without improvement
  • Severe symptoms with high fever (>39°C/102.2°F) with purulent nasal discharge
  • Initial improvement followed by worsening symptoms (double-worsening pattern) 2

Treatment Duration and Monitoring

  • Typical treatment duration: 5-7 days 2
  • Assess for clinical improvement within 72 hours of starting antibiotics
  • Consider broader-spectrum antibiotic if no improvement after 72 hours 2

Common Pitfalls to Avoid

  1. Using first-generation cephalosporins like cephalexin for sinusitis when they lack appropriate coverage
  2. Treating viral sinusitis with antibiotics - most cases of sinusitis are viral and resolve without antibiotics
  3. Failing to consider local resistance patterns when selecting therapy
  4. Not addressing underlying conditions (allergies, anatomical abnormalities) that may contribute to sinusitis

In conclusion, while cephalexin may have shown some efficacy in older studies, current guidelines clearly indicate it is not an appropriate choice for bacterial sinusitis due to its inadequate coverage of common respiratory pathogens.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The efficacy of cefdinir in acute bacterial rhinosinusitis.

Expert opinion on pharmacotherapy, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.